# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4345562 | F | Antimicrobial activity against Neisseria meningitidis MC58 assessed as bacterial growth inhibition measured after 18 to 20 hrs | Neisseria meningitidis | 2 | organism-based format | Scientific Literature | ||
2. | ALA4345563 | F | Antimicrobial activity against Haemophilus influenzae H2192 assessed as bacterial growth inhibition measured after 18 to 20 hrs | Haemophilus influenzae | 2 | organism-based format | Scientific Literature | ||
3. | ALA4345564 | F | Anti-chlamydial activity against Chlamydia trachomatis Serovar LGV-L2 infected in Hep2 cells assessed as inhibition of chlamydial inclusion at 50 ug/ml treated at 8 hrs post infection and measured at 24 hrs post-infection by immunofluorescence assay | Chlamydia trachomatis | 35 | organism-based format | Scientific Literature | ||
4. | ALA4345566 | F | Anti-chlamydial activity against Chlamydia trachomatis Serovar LGV-L2 infected in Hep2 cells assessed as reduction in chlamydial infectivity by measuring decrease in inclusion forming units at 50 ug/ml treated at 8 hrs post-infection and 24 hrs later re-infecting fresh Hep2 cells monolayer with infected cells and measured at 24 hrs post re-infection by immunofluorescence staining based microscopy analysis | Chlamydia trachomatis | 8 | organism-based format | Scientific Literature | ||
5. | ALA4345577 | F | Anti-Chlamydial activity against Chlamydia trachomatis Serovar LGV-L2 infected in Hep2 cells assessed as reduction in size and number of chlamydial inclusion at 50 ug/ml treated at 8 hrs post-infection and 24 hrs later re-infecting fresh Hep2 cells monolayer with infected cells and measured at 24 hrs post re-infection by immunofluorescence staining based microscopy analysis | Chlamydia trachomatis | 1 | organism-based format | Scientific Literature |